Home Rekrutierung

Rekrutierung

Eingeschlossene Patienten: 23.726 (Stand 04. September 2025)
Amgevita® (Adalimumab)263
Benepali® (Etanercept)1301
Cimzia® (Certolizumab)1061
Enbrel® (Etanercept)2878
Erelzi® (Etanercept)619
Flixabi® (Infliximab)10
Hukyndra® (Adalimumab)18
Hulio® (Adalimumab)307
Humira® (Adalimumab)2912
Hyrimoz® (Adalimumab)284
Idacio® (Adalimumab)73
Imraldi® (Adalimumab)247
Inflectra™ (Infliximab)16
Jyseleca® (Filgotinib)183
Kevzara® (Sarilumab)238
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)105
Olumiant® (Baricitinib)562
Orencia® (Abatacept)998
Remicade® (Infliximab)762
Remsima® (Infliximab)27
Rinvoq® (Upadacitinib)351
Rixathon® (Rituximab)20
RoActemra® (Tocilizumab)1381
Ruxience® (Rituximab)1
Simponi® (Golimumab)480
Truxima® (Rituximab)8
Tyenne® (Tocilizumab)72
Xeljanz® (Tofacitinib)404
Yuflyma® (Adalimumab)72
Zessly® (Infliximab)2
Kontrollen6523